Showing 2751-2760 of 4063 results for "".
- FDA Issues New Policy for Remote Ophthalmic Assessment and Monitoring Devices During COVID-19https://modernod.com/news/fda-issues-new-policy-for-remote-ophthalmic-assessment-and-monitoring-devices-during-covid-19/2477535/The FDA issued immediate guidance to help expand the capability of remote ophthalmic assessment and monitoring devices. These devices include visual acuity charts, visual field devices, general use ophthalmic cameras, and tonometers. This guidance is intended to help facilitate patient c
- Sun Pharmaceutical Donates 2.5 Million Hydroxychloroquine Sulfate Tablets in the US For Potential COVID-19 Treatmenthttps://modernod.com/news/sun-pharmaceutical-donates-2-5-million-hydroxychloroquine-sulfate-tablets-in-the-us-for-potential-covid-19-treatment/2477480/Sun Pharmaceutical Industries announced that it has donated 2.5 million hydroxychloroquine sulfate tablets for use in the United States. Sun Pharma is seeking to enable health care experts meet the growing patient demands for this product as they assess its potential to treat COVID-19 through cli
- UK Commits £210 Million Toward Global Efforts to Find COVID-19 Vaccinehttps://modernod.com/news/uk-commits-210-million-toward-global-efforts-to-find-covid-19-vaccine/2477469/The UK government said it would contribute £210 million ($255 million) toward international efforts aimed at finding a vaccine against the novel coronavirus, according to a FirstWord report. The funding will be channelled to the Coalition for Epidemic Preparedness Innovations (CEPI), which
- CooperVision Announces 2020 Best Practices Honoreeshttps://modernod.com/news/coopervision-announces-2020-best-practices-honorees/2477447/CooperVision has unveiled its 2020
- Registration Now Open for Neuro-Optometric Rehabilitation Association (NORA) 2020 Annual Conferencehttps://modernod.com/news/registration-now-open-for-neuro-optometric-rehabilitation-association-nora-2020-annual-conference/2477365/Registration is now open for the Neuro-Optometric Rehabilitation Association, International (NORA) Clinical Skills Pre-Conference (September 10-11) and 29th annual General Conference (September 12-13) at the Hyatt Regency Columbus in Columbus, Ohio. “This year’s conference them
- Aldeyra Therapeutics to Provide Update on Late-Stage Clinical Development Pipeline at 2020 Research & Development Dayhttps://modernod.com/news/aldeyra-therapeutics-to-provide-update-on-late-stage-clinical-development-pipeline-at-2020-research-development-day/2477322/Aldeyra Therapeutics on Monday hosted the 2020 Research & Development Day (R&D Day) with investors and financial analysts in New York City to present recent clinical development updates and market opportun
- Fact.MR Highlights Accelerating Sales of Corrective Lenses; Contact Lens Market Set to Record 5% Through 2029https://modernod.com/news/fact-mr-highlights-accelerating-sales-of-corrective-lenses-contact-lens-market-set-to-record-5-through-2029/2477317/The proliferation of visually-impaired consumers and their participation in outdoor activities, coupled with increasing cases of myopia, presbyopia, and astigmatism, will drive the global contact lens market to witness a staggering growth trajectory of over 5% between 2019 and 2029, according to
- Iscalimab Promising for Sjogren’s Syndromehttps://modernod.com/news/iscalimab-promising-for-sjogrens-syndrome/2477313/The anti-CD40 monoclonal antibody iscalimab showed preliminary efficacy against Sjogren’s syndrome in a proof-of-concept study, according to a Reuters report. Although Sjogren’s syndrome is a relatively common condition
- SECO 20/20 Unveils Exclusive Lineup of “Special Sessions”https://modernod.com/news/seco-20-20-unveils-exclusive-lineup-of-special-sessions/2477292/SECO 20/20 has announced the list of 11 speakers who will be featured during the event’s Special Sessions. From March 4-8, 2020, SECO 20/20 will bring together optometric professionals from around the globe to discuss the latest innovations, while discovering cutting-edge lab techniques and infor
- Lineage Provides Positive Update on Phase 1/2a Clinical Study of OpRegen for the Treatment of Dry Age-Related Macular Degenerationhttps://modernod.com/news/lineage-provides-positive-update-on-phase-i-iia-clinical-study-of-opregen-for-the-treatment-of-dry-age-related-macular-degeneration/2477278/Lineage Cell Therapeutics a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today provided an update from its ongoing phase 1/2a clinical study of OpRegen, the company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry